diabetic macular edema

Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: a systematic review and meta-analysis
Allison Low, Ambar Faridi, Kavita V Bhavsar, Glenn C Cockerham, Michele Freeman, Rochelle Fu, Robin Paynter, Karli Kondo, Devan Kansagara

British Journal of Ophthalmology Apr 2019, 103 (4) 442-451; DOI: 10.1136/bjophthalmol-2018-312691
The effect of posterior vitreous detachment on aflibercept response in diabetic macular oedema
Cemal Özsaygili, Bekir Küçük, Yener Yildirim

British Journal of Ophthalmology Jun 2021, 105 (6) 800-805; DOI: 10.1136/bjophthalmol-2020-316155
Effect of segmentation error correction on optical coherence tomography angiography measurements in healthy subjects and diabetic macular oedema
Khalil Ghasemi Falavarjani, Abbas Habibi, Pasha Anvari, Shahriar Ghasemizadeh, Maryam Ashraf Khorasani, Hamideh Shenazandi, David Sarraf

British Journal of Ophthalmology Feb 2020, 104 (2) 162-166; DOI: 10.1136/bjophthalmol-2019-314018
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial
Hamid Ahmadieh, Ramin Nourinia, Ali Hafezi-Moghadam, Hamideh Sabbaghi, Shintaro Nakao, Souska Zandi, Mehdi Yaseri, Zahra Tofighi, Shadi Akbarian

British Journal of Ophthalmology Jul 2019, 103 (7) 922-927; DOI: 10.1136/bjophthalmol-2018-312244
Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema
Maria Vittoria Cicinelli, Michele Cavalleri, Lea Querques, Alessandro Rabiolo, Francesco Bandello, Giuseppe Querques

British Journal of Ophthalmology Dec 2017, 101 (12) 1689-1693; DOI: 10.1136/bjophthalmol-2017-310242

Log in using your username and password

Main menu

Log in using your username and password

You are here

diabetic macular edema